학술논문
Brolucizumab 12- and 16-Week Fixed Dosing Potential in Neovascular AMD: A post hoc Evaluation of Data from the HAWK and HARRIER Trials
Document Type
Article
Author
Source
In: Ophthalmologica . (Ophthalmologica, 1 August 2022, 245(4):315-322)
Subject
Language
English
ISSN
14230267
00303755
00303755